PROVIDER PROFILE · NPI 1538250055

Adine ReganMD

UrologyFarmington, CTI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,285

Unique beneficiaries

—

Total services

1,637

Distinct HCPCS

Medicare payment

$97K

Peer benchmark

Total Medicare services vs. 130 Urology providers in CT — above median (cohort median 1,851).

PRESCRIBING · PART D · 2024

Total Rx claims

2,828

Beneficiaries

—

Total drug cost

$614K

Distinct drugs

Brand share

48.7%

Top prescribed drugs

Methenamine Hippurate362 claims

Mirabegron268 claims

Nitrofurantoin Monohyd/M-Cryst229 claims

Oxybutynin Chloride219 claims

Cephalexin217 claims

QUALITY · MIPS · 2024

Final MIPS score

90.4

Quality

83.4

Cost

75.9

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.65%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$51

Payment records

By payment type

Food and Beverage$51

REFERRAL NETWORK

Where Adine Regan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
HARTFORD HEALTHCARE LABORATORIES	119	269
ROSE, DONNA	113	224
Quest Diagnostics Llc Clinical Laboratory · Wallingford, CT	67	154
Mary Roche Nurse Practitioner · Farmington, CT	24	61
MANCHESTER MEMORIAL HOSPITAL	23	49
THE HOSPITAL OF CENTRAL CONNECTICUT AT NEW BRITAIN GENERAL AND BRADLEY	14	60

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history